Ailurus Biotechnology

Ailurus Biotechnology

呈元科技

Ailurus Biotechnology

Biotech/Healthcare

Incubated by Sinovation Ventures and founded in 2022, Chengyuan Technology has offices and R&D centers in Beijing, Shanghai, Guangzhou, and New Jersey. The company combines AI and biotechnology to address two global challenges: the efficient development of innovative biologic drugs and the…

Latest round: Series B (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-03-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.